Figure 6 Kaplan-Meier survival curves according to high and low expression of PLG, COPS5, FYN, ITGB3, IRF3, and SPTA1 in immune cell subgroups in PDAC, and their diagnostic value in PDAC. (A) Kaplan-Meier survival analysis of the high and low groups of PLG expression in patients with PDAC based on the number of tumor-infiltrating B cells, CD8+ T cells, NK cells, and macrophages. (B) Kaplan-Meier survival analysis of the high and low groups of COPS5 expression in patients with PDAC based on the number of tumor-infiltrating B cells, CD8+ T cells, NK cells, and macrophages. (C) Kaplan-Meier survival analysis of the high and low groups of FYN expression in patients with PDAC based on the number of tumor-infiltrating B cells, CD8+ T cells, NK cells, and macrophages. (D) Kaplan-Meier survival analysis of the high and low groups of ITGB3 expression in patients with PDAC based on the number of tumor-infiltrating B cells, CD8+ T cells, NK cells, and macrophages. (E) Kaplan-Meier survival analysis of the high and low groups of IRF3 expression in patients with PDAC based on the number of tumor-infiltrating B cells, CD8+ T cells, NK cells, and macrophages. (F) Kaplan-Meier survival analysis of the high and low groups of SPTA1 expression in patients with PDAC based on the number of tumor-infiltrating B cells, CD8+ T cells, NK cells, and macrophages (KM plotter, 2022.08.23, https://kmplot.com/analysis/).